SCHEDULE 13D/A

BRIDGEBIO PHARMA INC

Common Stock, par value $0.001 per share · CUSIP: 10806X102

Event date: 2025-05-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• KKR Genetic Disorder L.P.Reported CIK 0001780408

  Shares: 13,260,971 · Class: 7%

• KKR Genetic Disorder GP LLC

  Shares: 13,260,971 · Class: 7%

• KKR Group Partnership L.P.

  Shares: 13,260,971 · Class: 7%

• KKR Group Holdings Corp.

  Shares: 13,260,971 · Class: 7%

• KKR Group Co. Inc.

  Shares: 13,260,971 · Class: 7%

• KKR & Co. Inc.

  Shares: 13,260,971 · Class: 7%

• KKR Management LLP

  Shares: 13,260,971 · Class: 7%

• Henry R. Kravis

  Shares: 13,260,971 · Class: 7%

• George R. Roberts

  Shares: 13,260,971 · Class: 7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.